Covid 19 Research using Clinical Trials (Home Page)
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug28 | 2019-nCoV PCR Wiki | 1.00 |
Correlated MeSH Terms (1)
|
Name (Synonyms) |
Correlation |
D018352 | Coronavirus Infections NIH | 0.04 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
Despite prophylactic anticoagulant treatments, thrombotic complications may develop in
patients with Coronavirus disease 2019 (COVID-19). This study aimed to evaluate anti-Factor
Xa levels to determine the anticoagulant activity of low molecular weight heparin (LMWH) in
COVID-19 patients.
NCT04507282 COVID-19 Drug: LMWH
Primary Outcomes
Description: <0.2IU/ml
Measure: subprophylactic anticogulation level
Time: 14 days
No related HPO nodes (Using clinical trials)